Physician profile
Kenneth D Hillner
NPI 1518910611
$2,290.90
in general payments reported to CMS, 2019-2025
14 companies · $89.50 in 2025
The $89.50 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $118 · 2020: $59.52 · 2021: $1,560 · 2022: $188 · 2023: $112 · 2024: $164 · 2025: $89.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $366.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $365.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $1,343.25 | 2021 | |
| Novo Nordisk INC | $305.62 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Pfizer INC. | $186.11 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $131.90 | 2019-2024 | Farxiga |
| Lilly USA, LLC | $58.58 | 2022-2023 | Mounjaro |
| Bayer Healthcare Pharmaceuticals INC. | $45.12 | 2022 | |
| Merck Sharp & Dohme LLC | $44.09 | 2021-2025 | Gardasil 9, Vaxneuvance, Capvaxive |
| Abbott Laboratories | $33.90 | 2022 | |
| Exact Sciences Corporation | $33.18 | 2023 | Cologuard Collection Kit |
| Genentech USA, INC. | $28.84 | 2020-2021 | |
| Dexcom, INC. | $25.63 | 2025 | Dexcom G6 Transmitter |
| Abbvie INC. | $22.34 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.35 | 2019 | |
| Supernus Pharmaceuticals, INC. | $13.99 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Hillner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.